Literature DB >> 8282587

Hemodynamic changes associated with obstructive sleep apnea followed by arousal in a porcine model.

J M Pinto1, E Garpestad, J W Weiss, D M Bergau, D A Kirby.   

Abstract

To study the effects of airway obstruction (AWO) and arousal on coronary blood flow, mean arterial pressure (MAP), and heart rate, pigs were chronically instrumented with arterial catheters, Doppler flow probes on the left circumflex coronary artery, and electrodes for determination of sleep stages. A modified tracheostomy tube was placed in the trachea to obstruct the upper airway during sleep sessions. In control studies, during non-rapid-eye-movement (NREM) sleep, MAP was 84 +/- 2 mmHg before AWO and increased by 5 +/- 2 mmHg on arousal. MAP was lower during rapid-eye-movement (REM) sleep (62 +/- 2 mmHg), and the increase on arousal was fourfold greater (22 +/- 2 mmHg). Heart rate was similar in both sleep stages (NREM: 120 +/- 4 beats/min; REM: 124 +/- 5 beats/min) and increased significantly on arousal (NREM: 12 +/- 2 beats/min; REM: 18 +/- 1 beats/min). Coronary blood flow was similar during both stages (NREM: 43 +/- 4 ml/min; REM: 46 +/- 8 ml/min) and increased by 12-15% on arousal. Coronary vascular resistance index increased significantly by 24% on arousal from AWO during REM sleep. All increases and decreases were significant at P < 0.05. Receptor blockade studies were performed to assess alpha-adrenergic receptor involvement.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8282587     DOI: 10.1152/jappl.1993.75.4.1439

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  15 in total

Review 1.  Sleep Apnea Research in Animals. Past, Present, and Future.

Authors:  Swati Chopra; Vsevolod Y Polotsky; Jonathan C Jun
Journal:  Am J Respir Cell Mol Biol       Date:  2016-03       Impact factor: 6.914

Review 2.  Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components.

Authors:  Girardin Jean-Louis; Ferdinand Zizi; Luther T Clark; Clinton D Brown; Samy I McFarlane
Journal:  J Clin Sleep Med       Date:  2008-06-15       Impact factor: 4.062

3.  Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model.

Authors:  D Brooks; R L Horner; L F Kozar; C L Render-Teixeira; E A Phillipson
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

4.  Obstructive sleep apnoea/hypopnoea syndrome and hypertension.

Authors:  Mohammed A Al-Abri; Khamis M Al-Hashmi
Journal:  Sultan Qaboos Univ Med J       Date:  2008-11

Review 5.  Sleep duration and the risk of diabetes mellitus: epidemiologic evidence and pathophysiologic insights.

Authors:  Ferdinand Zizi; Girardin Jean-Louis; Clinton D Brown; Gbenga Ogedegbe; Carla Boutin-Foster; Samy I McFarlane
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

Review 6.  The Link Between Obstructive Sleep Apnea and Cardiovascular Disease.

Authors:  Fré Bauters; Ernst R Rietzschel; Katrien B C Hertegonne; Julio A Chirinos
Journal:  Curr Atheroscler Rep       Date:  2016-01       Impact factor: 5.113

7.  Obstructive sleep apnea leads to transient uncoupling of coronary blood flow and myocardial work in humans.

Authors:  Garun S Hamilton; Ian T Meredith; Adrian M Walker; Peter Solin
Journal:  Sleep       Date:  2009-02       Impact factor: 5.849

Review 8.  Animal models of sleep disorders.

Authors:  Linda A Toth; Pavan Bhargava
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

9.  Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study.

Authors:  George T O'Connor; Brian Caffo; Anne B Newman; Stuart F Quan; David M Rapoport; Susan Redline; Helaine E Resnick; Jonathan Samet; Eyal Shahar
Journal:  Am J Respir Crit Care Med       Date:  2009-03-05       Impact factor: 21.405

10.  Coronary blood flow becomes uncoupled from myocardial work during obstructive sleep apnea in the presence of endothelial dysfunction.

Authors:  Garun S Hamilton; Peter Solin; Adrian Walker
Journal:  Sleep       Date:  2008-06       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.